Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1994-03-17
1997-02-04
Stone, Jacqueline M.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 241, 536 242, 536 245, C12N 1500, C12N 500, A61K 4800
Patent
active
055999174
ABSTRACT:
Oligonucleotides and analogs thereof that bind to and preferably modulate the activity of interferon-.gamma., and methods for their use, including therapeutic and diagnostic methods are disclosed.
REFERENCES:
patent: 5087617 (1992-02-01), Smith
patent: 5190873 (1993-03-01), Lernhardt et al.
patent: 5212083 (1993-05-01), Haldenwang
patent: 5248671 (1993-09-01), Smith
patent: 5270163 (1993-12-01), Gold et al.
patent: 5459015 (1995-10-01), Janjic et al.
Jacob et al., J. Exp. Med., 166:798(1987).
Umland et al., Clin. Immun. Immunopath., 63:66(1992).
Bock et al., Nature, 355:565 (1992).
Aguet et al. Cell 55:273-280 (1988).
Balkwill et al Immunol Today 10(9):299-303 (1989).
Gimble et al Exp Hemat. 21:224-230 (1993).
Guha et al Cell. Immunol 151(2):404-413.
Valente et al Eur. J Immunol 22:2403-2412 (1992).
Bertelsen Arthur H.
Beutel Bruce A.
Coppola George R.
Herron Charles J.
Milne Andrew
Olstein Elliot M.
PharmaGenics, Inc.
Stone Jacqueline M.
LandOfFree
Inhibition of interferon-.gamma. with oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of interferon-.gamma. with oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of interferon-.gamma. with oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-679791